Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, Data Summary from January 1996 through December 1997

American Journal of Infection Control

Volumn 27, Issue 3, 1999, Pages 279-284

  Fridkin, Scott K ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; MONOBACTAM DERIVATIVE; PENEM DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; DRUG SURVEILLANCE PROGRAM; DRUG USE; HOSPITAL INFECTION; HOSPITAL PHARMACY; HUMAN; INTENSIVE CARE; MICROBIOLOGY;

EID: 0033039856     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1053/ic.1999.v27.a98878     Document Type: Article

References (10)

1. 1. Fridkin SK, Steward CD. Edwards JR, McGowan JE Jr, Culver DH, Gaynes RP, et al. Surveillance of antimicrobial use and antimicrobial resistance in U.S. hospitals: project ICARE phase 2. Clin Infect Dis. In press 1999.
2. 2. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996;275:234-40.
3. 3. Emori G, Culver DH, Horan TC, Jarvis WR, Olson DR, Banerjee S, et al. National nosocomial infections surveillance (NNIS): description of surveillance methods. AJIC Am J Infect Control 1991;19:19-35.
4. 4. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS approved standard M7-A3. Villanova (PA): National Committee for Clinical Laboratory Standards; 1993.
5. 5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. NCCLS approved standard M2-A5. Villanova (PA): National Committee for Clinical Laboratory Standards; 1993.
6. 6. Monnet DL, Archibald LK, Phillips L, Tenover FC, McGowan JE Jr, Gaynes RP, et al. Antimicrobial use and resistance in eight U.S. hospitals: complexities of analysis and modeling. Infect Control Hosp Epidemiol 1998;19:388-94.
7. 7. Amsden GW, Schentag JJ, Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995. p. 492-528.
8. 8. Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the preventions of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997; 18:275-91.
9. 9. Gold HS, Moellering RCJ. Antimicrobial-drug resistance. N Engl J Med 1996;335:1445-53.
10. 10. Fridkin SK, Edwards JR, Pryor ER, McGowan JE Jr, Tenover FC, Culver DH, et al. Determinants of vancomycin use in adult intensive care units at U.S. hospitals. Clin Infect Dis. In press 1999.